AMLX
Amylyx Pharmaceuticals Inc
30.60$
-7.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.03 | 0.01 | 0.00 | 0.33 | 5.44 | 1.28 | 0.00 | |
| 0.21 | 0.44 | 0.00 | 0.04 | 0.36 | 0.62 | 0.01 | |
| -0.19 | -0.42 | 0.00 | 0.29 | 5.08 | 0.66 | -0.01 | |
| 0.21 | 0.44 | 0.76 | 1.41 | 1.83 | 1.53 | 0.96 | |
| 0.05 | 0.26 | 0.67 | 1.91 | 2.56 | 1.64 | 0.67 | |
| 0.24 | 0.27 | 1.43 | 3.32 | 4.52 | 5.28 | 1.62 | |
| -0.24 | -0.69 | -1.43 | -3.03 | 0.55 | -4.62 | -1.62 | |
| 0.02 | 0.04 | 0.00 | 0.06 | – | – | – | |
| -0.24 | -0.75 | -1.52 | -2.97 | 0.78 | -4.43 | -1.53 | |
| 0.02 | 0.05 | 0.00 | 0.01 | 0.07 | -0.01 | 0.00 | |
| -0.26 | -0.75 | -1.52 | -2.98 | 0.70 | -4.43 | -1.53 | |
| 0.02 | -0.69 | -1.43 | -3.02 | 0.79 | -4.27 | -1.52 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.